Finding the right teicoplanin dose for blood cancer or critically ill patients
Part of Blood & lymphatic, Cancer clinical trials.
This study is testing a smarter way to give the antibiotic teicoplanin to people with blood cancers or severe illnesses. The goal is to make sure each person gets the right dose to fight the infection while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 20 years old.
- You must have a blood cancer (like leukemia or lymphoma) or be critically ill.
- You must be taking teicoplanin (an antibiotic) for a fever caused by a suspected bacterial infection for at least 48 hours.
- You cannot be on kidney dialysis (renal dialysis) when you start teicoplanin.
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at when to start antibiotics early for blood cancer patients who may be carrying resistant bacteria (that are hard to treat). It aims to find the best time to treat these infections to improve outcomes.
This study looks at why some antibiotics given through a vein may reach infections differently in very sick children. It aims to make sure medicines are given in the best way to help children in the intensive care unit recover.
This study tests whether giving antibiotics in a personalized way, based on how your body processes them, works better than the standard dose for treating lung infections in the ICU. If you qualify, you'll be randomly assigned to get either the usual dose or a dose adjusted to your blood levels, with the goal of improving your recovery.
This study tests a new way to check if you are allergic to the antibiotic teicoplanin using your own blood serum. It aims to help doctors know for sure if you had a severe allergic reaction during a past surgery.
This trial tests whether using a blood test called procalcitonin (PCT) can help doctors decide when to use antibiotics for critically ill patients in the intensive care unit (ICU). It may help reduce unnecessary antibiotics and improve care.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
Hear when a new Hematological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.